British Columbia Investment Management Corp Alkermes Plc. Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$17.29 - $21.74 $371,199 - $466,736	-21,469 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $572,813 - $712,860	-29,360 Reduced 57.76%	21,469 $419,000
Q2 2019 Aug 12, 2019	BUY	$21.47 - $37.33 $464,095 - $806,925	21,616 Added 73.99%	50,829 $1.15 Million
Q1 2019 May 08, 2019	SELL	$28.4 - $36.49 $281,273 - $361,396	-9,904 Reduced 25.32%	29,213 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$27.94 - $44.61 $132,910 - $212,209	4,757 Added 13.84%	39,117 $1.15 Million
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $481,998 - $575,900	-12,487 Reduced 26.65%	34,360 $1.46 Million
Q2 2018 Aug 09, 2018	SELL	$40.56 - $51.36 $845,959 - $1.07 Million	-20,857 Reduced 30.81%	46,847 $1.93 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $182,220 - $228,616	3,399 Added 5.29%	67,704 $3.92 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $3.16 Million - $3.5 Million	64,305	64,305 $3.27 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$868 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$566 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$387 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$377 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$274 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account